{"id":39893,"date":"2021-08-03T15:24:00","date_gmt":"2021-08-03T08:24:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2021080315240039893"},"modified":"2021-08-03T21:39:28","modified_gmt":"2021-08-03T13:39:28","slug":"glenmark%e4%b8%8esanotize%e8%be%be%e6%88%90%e5%8d%8f%e8%ae%ae","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2021080315240039893","title":{"rendered":"Glenmark\u4e0eSaNOtize\u8fbe\u6210\u534f\u8bae"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/www.xinwengao.com\/cn\/wp-content\/uploads\/PRNE_Glenmark_Logo.jpg\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li><i>\u4e00\u6c27\u5316\u6c2e\u5177\u6709\u6297\u83cc\u6027\uff0c<\/i><i>\u5bf9\u65b0\u51a0\u75c5\u6bd2\u6709\u7ecf\u8fc7\u8bc1\u5b9e\u7684\u76f4\u63a5\u6548\u679c<\/i>&nbsp; <\/li>\n<li><i>\u4e00\u6c27\u5316\u6c2e\u9f3b<\/i><i>\u55b7\u96fe\u5242\uff08<\/i><i>NONS<\/i><i>\uff09\u5df2\u4f5c<\/i><i>\u4e3a\u82f1\u56fd\u548c\u52a0\u62ff\u5927\u4e34\u5e8a\u8bd5\u9a8c<sup>[<\/sup><\/i><i><sup>1]<\/sup><\/i>\u7684\u4e00\u90e8\u5206\uff0c\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u548c\u60a3\u8005\u4e2d\u8fdb\u884c\u4e86\u6d4b\u8bd5&nbsp;<\/li>\n<\/ul>\n<p><p>\u5370\u5ea6\u5b5f\u4e70\u548c\u5351\u8bd7\u7701\u6e29\u54e5\u534e2021\u5e748\u67083\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u4ee5\u7814\u7a76\u4e3a\u4e3b\u5bfc\u7684\u5168\u7403\u7efc\u5408\u5236\u836f\u516c\u53f8Glenmark Pharmaceuticals\u548c\u52a0\u62ff\u5927\u751f\u7269\u6280\u672f\u516c\u53f8SaNOtize Research &amp; Development Corp.\u4eca\u5929\u5ba3\u5e03\u5efa\u7acb\u72ec\u5bb6\u957f\u671f\u6218\u7565\u5408\u4f5c\u4f19\u4f34\u5173\u7cfb\uff0c\u5728\u5370\u5ea6\u548c\u5305\u62ec<i>\u65b0\u52a0\u5761\u3001<\/i><i>\u9a6c\u6765\u897f\u4e9a\u3001\u9999\u6e2f\u3001\u53f0\u6e7e\u3001\u5c3c\u6cca\u5c14\u3001\u6587\u83b1\u3001\u67ec\u57d4\u5be8\u3001\u8001\u631d\u3001\u7f05\u7538\u3001\u65af\u91cc\u5170\u5361\u3001\u4e1c\u5e1d\u6c76\u548c\u8d8a\u5357\u5728\u5185\u7684\u5176\u4ed6\u4e9a\u6d32\u5e02\u573a\u751f\u4ea7\u3001\u8425\u9500\u548c\u5206\u9500\u5176\u7a81\u7834\u6027\u7684\u4e00\u6c27\u5316\u6c2e\u9f3b\u55b7\u5242\uff08<\/i><i>NONS<\/i><i>\uff09\uff0c\u7528\u4e8e\u65b0\u51a0\u75c5\u6bd2\u6cbb<\/i><i>\u7597\u3002<\/i>&nbsp;<\/p>\n<p>2021\u5e743\u6708\uff0cSaNOtize\u7684\u4e34\u5e8a\u8bd5\u9a8c\u8868\u660e\uff0cNONS\u662f\u4e00\u6b3e\u5b89\u5168\u6709\u6548\u7684\u6297\u75c5\u6bd2\u6cbb\u7597\u836f\u7269\uff0c\u53ef\u9632\u6b62\u65b0\u51a0\u75c5\u6bd2\u7684\u4f20\u64ad\uff0c\u7f29\u77ed\u5176\u75c5\u7a0b\u5e76\u51cf\u8f7b\u75c7\u72b6\u7684\u4e25\u91cd\u7a0b\u5ea6\u3002\u5728\u6700\u521d\u768424\u5c0f\u65f6\uff0cNONS\u5c06\u5e73\u5747\u75c5\u6bd2\u8f7d\u91cf\u964d\u4f4e\u4e86\u7ea695%\uff0c\u5e76\u572872\u5c0f\u65f6\u5185\u51cf\u5c1199%\u4ee5\u4e0a\u3002\u4f5c\u4e3a\u82f1\u56fd\u548c\u52a0\u62ff\u5927\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4e00\u90e8\u5206\uff0c\u5df2\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u548c\u60a3\u8005\u4e2d\u8fdb\u884c\u4e86\u6d4b\u8bd5\u3002<\/p>\n<p>\u8fd9\u6b3e\u836f\u7269\u4ee5\u7b80\u5355\u7684\u9f3b\u8154\u55b7\u5242\u5f62\u5f0f\u63d0\u4f9b\uff0c\u65e8\u5728\u6740\u6b7b\u4e0a\u547c\u5438\u9053\u75c5\u6bd2\uff0c\u9632\u6b62\u5176\u6ecb\u751f\u5e76\u4f20\u64ad\u5230\u80ba\u90e8\u3002\u5b83\u662f\u4e00\u79cd\u5929\u7136\u7eb3\u7c73\u5206\u5b50\u4e00\u6c27\u5316\u6c2e\uff08NO\uff09\uff0c\u5df2\u88ab\u8bc1\u660e\u5177\u6709\u6297\u83cc\u6027\u80fd\uff0c\u5bf9\u5bfc\u81f4\u65b0\u51a0\u80ba\u708e\u7684SARS-CoV-2\u75c5\u6bd2\u6709\u76f4\u63a5\u4f5c\u7528\u3002<\/p>\n<p>2021\u5e747\u6708\u521d\uff0cGlenmark\u5411\u5370\u5ea6\u4e2d\u592e\u836f\u54c1\u6807\u51c6\u7ba1\u5236\u7ec4\u7ec7\uff08CDSCO\uff09\u4e3b\u9898\u4e13\u5bb6\u59d4\u5458\u4f1a\u63d0\u4ea4\u4e86\u4e00\u4efd\u63d0\u6848\uff0c\u8981\u6c42\u7d27\u6025\u6279\u51c6NONS\u7684\u8fdb\u53e3\u548c\u9500\u552e\u3002\u59d4\u5458\u4f1a\u5efa\u8bae\u5728\u5370\u5ea6\u60a3\u8005\u4e2d\u8fdb\u884cIII\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002NONS\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u9884\u8ba1\u5c06\u4e8e2021\u5e74\u5386\u5e74\u7b2c\u56db\u5b63\u5ea6\u5b8c\u6210\uff0c\u968f\u540e\u5c06\u4ee5FabiSpray&reg;\u54c1\u724c\u540d\u79f0\u5728\u5370\u5ea6\u5546\u4e1a\u53d1\u552e\u3002<\/p>\n<p><b><i>\u201c<\/i><\/b><b><i>\u81ea\u65b0\u51a0\u80ba\u708e\u7206<\/i><\/b><b><i>\u53d1\u4ee5\u6765\uff0c\u6211\u4eec\u4e00\u76f4\u52aa\u529b\u4e3a\u60a3\u8005\u63d0\u4f9b\u5b89\u5168\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6848\u6765\u5bf9\u6297\u8fd9\u4e00\u75be\u75c5\u3002\u4e0e<\/i><\/b><b><i>SaNOtize<\/i><\/b><b><i>\u7684\u5408\u4f5c<\/i><\/b><b><i>\u7d27\u5bc6\u8d34\u5408<\/i><\/b><b><i>Glenmark<\/i><\/b><b><i>\u9488\u5bf9\u65b0\u51a0\u80ba\u708e\u7684\u4e3b\u8981\u65b9\u6cd5\uff0c\u5e76\u5c06\u6709\u52a9\u4e8e\u51cf\u8f7b\u8be5\u5730\u533a\u75ab\u60c5\u7684\u8d1f\u62c5\uff0c<\/i><\/b><b><i>\u201dGlenmark Pharmaceuticals Ltd<\/i><\/b><b><i>\u8463\u4e8b<\/i><\/b><b><i>\u957f\u517c\u603b\u7ecf\u7406<\/i><\/b><b><i><span class=\"xn-person\">Glenn Saldanha<\/span><\/i><\/b><b><i>\u8868\u793a\u3002\u4ed6<\/i><\/b><b><i>\u8fdb\u4e00\u6b65\u8865\u5145\u8bf4\uff1a<\/i><\/b><b><i>\u201c<\/i><\/b><b><i>\u8fd9\u4e5f\u6807\u5fd7\u7740\u6211\u4eec\u5728\u5173\u952e\u7684\u547c\u5438\u836f\u54c1\u6cbb\u7597\u9886\u57df\u7684\u53e6\u4e00\u5b9d\u8d35\u7684\u5f15\u5165\u8bb8\u53ef\u673a\u4f1a\uff0c\u4ee5\u53ca\u5728\u5168\u7403\u8303\u56f4\u5185\u5411<\/i><\/b><b><i>SaNOtize<\/i><\/b><b><i>\u53ca\u5176\u5408\u4f5c\u4f19\u4f34\u4f9b<\/i><\/b><b><i>\u5e94\u8be5\u4ea7\u54c1\u7684\u53ef\u80fd\u6027\u3002<\/i><\/b><b><i>Glenmark<\/i><\/b><b><i>\u5c06\u786e\u4fdd\u53ca<\/i><\/b><b><i>\u65f6\u548c\u5e7f\u6cdb\u83b7\u5f97\u8fd9\u79cd\u6709\u6548\u7684\u9f3b\u8154\u55b7\u96fe\uff0c\u6211\u4eec\u5e0c\u671b\u8fd9\u5c06\u4e3a\u8be5\u5730\u533a\u53ca\u5168\u4e16\u754c\u7684\u60a3\u8005\u5e26\u6765\u6025\u9700\u7684\u7f13\u89e3\u3002<\/i><\/b><b><i>\u201d<\/i><\/b><b>&nbsp;<\/b><\/p>\n<p><b><i>\u201c<\/i><\/b><b><i>\u4e8b<\/i><\/b><b><i>\u5b9e\u8bc1\u660e\uff0c\u5c3d\u7ba1\u75ab\u82d7\u5f00\u53d1\u8fc5\u901f\u5e76\u4e14\u5173\u952e\uff0c\u4f46\u65b0\u51a0\u75c5\u6bd2\u53ca\u5176\u5404\u79cd\u53d8\u79cd\u4ecd\u662f\u9700\u8981\u904f\u5236\u7684\u6311\u6218\uff0c<\/i><\/b><b><i>\u201d SaNOtize<\/i><\/b><b><i>\u9996\u5e2d<\/i><\/b><b><i>\u6267\u884c\u5b98\u53ca\u8054\u5408\u521b\u59cb\u4eba<\/i><\/b><b><i><span class=\"xn-person\">Gilly Regev<\/span><\/i><\/b><b><i>\u8868\u793a\u3002<\/i><\/b><b><i>\u201cSaNOtize<\/i><\/b><b><i>\u5f88\u9ad8<\/i><\/b><b><i>\u5174\u80fd\u4e0e<\/i><\/b><b><i>Glenmark<\/i><\/b><b><i>\u5408\u4f5c\uff0c\u4f7f\u5176\u6cbb<\/i><\/b><b><i>\u7597\u836f\u7269\u66f4\u7b80\u5355\u5730\u8ba9\u66f4\u591a\u7684\u4eba\u7528\u5f97\u5230\u3001\u7528\u5f97\u8d77\u3002<\/i><\/b><b><i>&nbsp;<\/i><\/b><b><i>\u5728\u4e0e<\/i><\/b><b><i>Glenmark<\/i><\/b><b><i>\u643a\u624b\u5408\u4f5c\u7684<\/i><\/b><b><i>\u8fc7\u7a0b\u4e2d\uff0c<\/i><\/b><b><i>SaNOtize<\/i><\/b><b><i>\u53ef\u4ee5\u52a0\u5feb\u52aa\u529b\u901f\u5ea6\uff0c\u4f7f\u5176\u6297\u75c5\u6bd2\u9f3b\u8154<\/i><\/b><b><i>\u55b7\u5242\u5728\u5f53\u524d\u75ab\u60c5\u671f\u95f4\u4f5c\u4e3a\u81ea\u5df1\u7ed9\u836f\u5bf9\u6297\u65b0\u51a0\u80ba\u708e\u7684\u7b2c\u4e00\u9053\u9632\u7ebf\uff0c\u5e76\u5e2e\u52a9\u9632\u6b62\u672a\u6765\u75ab\u60c5\u7206\u53d1\u3002<\/i><\/b><b><i>\u201d<\/i><\/b><b>&nbsp;<\/b><\/p>\n<p>NONS\u662f\u6602\u8d35\u7684\u5355\u514b\u9686\u6297\u4f53\u4ee5\u5916\u4e3a\u6570\u4e0d\u591a\u7684\u51e0\u79cd\u65b0\u578b\u6cbb\u7597\u65b9\u6cd5\u4e4b\u4e00\uff0c\u5df2\u88ab\u8bc1\u660e\u53ef\u4ee5\u51cf\u5c11\u4eba\u4f53\u4e2d\u65b0\u51a0\u75c5\u6bd2\u8f7d\u91cf\u3002<sup>[2]<\/sup>NONS\u5df2\u5728\u6b27\u6d32\u83b7\u5f97CE\u6807\u5fd7\uff0c\u8fd9\u76f8\u5f53\u4e8e\u533b\u7597\u5668\u68b0\u7684\u4e0a\u5e02\u8bb8\u53ef\uff08CE\u6807\u5fd7\u786e\u8ba4\u533b\u7597\u5668\u68b0\u7b26\u5408\u6b27\u6d32\u901a\u7528\u533b\u7597\u5668\u68b0\u6307\u4ee4\u7684\u67d0\u4e9b\u201c\u57fa\u672c\u8981\u6c42\u201d\uff0c\u5e76\u4e14\u5bf9\u9884\u671f\u7528\u9014\u662f\u5b89\u5168\u7684\uff09\u3002\u51ed\u501fCE\u6807\u5fd7\uff0cSaNOtize\u5df2\u83b7\u5f97\u5728\u6b27\u6d32\u53d1\u5e03NONS\u7684\u8bb8\u53ef\u3002NONS\u4e5f\u83b7\u5f97\u4e86\u5728\u4ee5\u8272\u5217\u548c\u5df4\u6797\u4ee5\u540d\u79f0enovid<sup>&#x2122;<\/sup>\u8fdb\u884c\u9500\u552e\u7684\u8bb8\u53ef\u3002<\/p>\n<p>SaNOtize\u57282017\u5e74\u5f00\u53d1\u4e86\u7528\u4e8e\u6cbb\u7597\u548c\u9884\u9632\u5fae\u751f\u7269\u611f\u67d3\u7684\u4e00\u6c27\u5316\u6c2e\u91ca\u653e\u6eb6\u6db2\u5e73\u53f0\u6280\u672f\uff08NORS<sup>&#x2122;<\/sup>\uff09\u5e76\u83b7\u5f97\u4e86\u4e13\u5229\u3002Glenmark\u4e0eSaNOtize\u7684\u5408\u4f5c\u5c06\u4e3a\u5370\u5ea6\u548c\u4e9a\u6d32\u7684\u60a3\u8005\u5e26\u6765\u6025\u9700\u7684\u6cbb\u7597\u7f13\u89e3\u3002<\/p>\n<p><sup>[1]<\/sup>SaNOtize\u7684\u201c\u9769\u547d\u6027\u201d\u65b0\u51a0\u75c5\u6bd2\u9f3b\u55b7\u96fe\u83b7\u5f97II\u671f\u4e34\u5e8a\u6570\u636e\u652f\u6301\u3002\u8be6\u60c5\u8bf7\u8bbf\u95ee<a target=\"_blank\" href=\"https:\/\/www.clinicaltrialsarena.com\/news\/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail\/\" rel=\"nofollow noopener\">https:\/\/www.clinicaltrialsarena.com\/news\/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail\/<\/a><\/p>\n<p><sup>[2]<\/sup>SaNOtize\u7684\u201c\u9769\u547d\u6027\u201d\u65b0\u51a0\u75c5\u6bd2\u9f3b\u55b7\u96fe\u83b7\u5f97II\u671f\u4e34\u5e8a\u6570\u636e\u652f\u6301\u3002\u8be6\u60c5\u8bf7\u8bbf\u95ee<a target=\"_blank\" href=\"https:\/\/www.clinicaltrialsarena.com\/news\/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail\/\" rel=\"nofollow noopener\">https:\/\/www.clinicaltrialsarena.com\/news\/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail\/<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e00\u6c27\u5316\u6c2e\u5177\u6709\u6297\u83cc\u6027\uff0c\u5bf9\u65b0\u51a0\u75c5\u6bd2\u6709\u7ecf\u8fc7\u8bc1\u5b9e\u7684\u76f4\u63a5\u6548\u679c&nbsp; \u4e00\u6c27\u5316\u6c2e\u9f3b\u55b7\u96fe\u5242\uff08NONS\uff09\u5df2\u4f5c\u4e3a\u82f1\u56fd\u548c\u52a0\u62ff\u5927\u4e34\u5e8a\u8bd5\u9a8c[1]\u7684\u4e00\u90e8\u5206\uff0c\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u548c\u60a3\u8005\u4e2d\u8fdb\u884c\u4e86\u6d4b\u8bd5&nbsp; \u5370\u5ea6\u5b5f\u4e70\u548c\u5351\u8bd7\u7701\u6e29\u54e5\u534e2021\u5e748\u67083\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u4ee5\u7814\u7a76\u4e3a\u4e3b\u5bfc\u7684\u5168\u7403\u7efc\u5408\u5236\u836f\u516c\u53f8Glenmark Pharmaceuticals\u548c\u52a0\u62ff\u5927\u751f\u7269\u6280\u672f\u516c\u53f8SaNOtize Research &amp; Development Corp.\u4eca\u5929\u5ba3\u5e03\u5efa\u7acb\u72ec\u5bb6\u957f\u671f\u6218\u7565\u5408\u4f5c\u4f19\u4f34\u5173\u7cfb\uff0c\u5728\u5370\u5ea6\u548c\u5305\u62ec\u65b0\u52a0\u5761\u3001\u9a6c\u6765\u897f\u4e9a\u3001\u9999\u6e2f\u3001\u53f0\u6e7e\u3001\u5c3c\u6cca\u5c14\u3001\u6587\u83b1\u3001\u67ec\u57d4\u5be8\u3001\u8001\u631d\u3001\u7f05\u7538\u3001\u65af\u91cc\u5170\u5361\u3001\u4e1c\u5e1d\u6c76\u548c\u8d8a\u5357\u5728\u5185\u7684\u5176\u4ed6\u4e9a\u6d32\u5e02\u573a\u751f\u4ea7\u3001\u8425\u9500\u548c\u5206\u9500\u5176\u7a81\u7834\u6027\u7684\u4e00\u6c27\u5316\u6c2e\u9f3b\u55b7\u5242\uff08NONS\uff09\uff0c\u7528\u4e8e\u65b0\u51a0\u75c5\u6bd2\u6cbb\u7597\u3002&nbsp; 2021\u5e743\u6708\uff0cSaNOtize\u7684\u4e34\u5e8a\u8bd5\u9a8c\u8868\u660e\uff0cNONS\u662f\u4e00\u6b3e\u5b89\u5168\u6709\u6548\u7684\u6297\u75c5\u6bd2\u6cbb\u7597\u836f\u7269\uff0c\u53ef\u9632\u6b62\u65b0\u51a0\u75c5\u6bd2\u7684\u4f20\u64ad\uff0c\u7f29\u77ed\u5176\u75c5\u7a0b\u5e76\u51cf\u8f7b\u75c7\u72b6\u7684\u4e25\u91cd\u7a0b\u5ea6\u3002\u5728\u6700\u521d\u768424\u5c0f\u65f6\uff0cNONS\u5c06\u5e73\u5747\u75c5\u6bd2\u8f7d\u91cf\u964d\u4f4e\u4e86\u7ea695%\uff0c\u5e76\u572872\u5c0f\u65f6\u5185\u51cf\u5c1199%\u4ee5\u4e0a\u3002\u4f5c\u4e3a\u82f1\u56fd\u548c\u52a0\u62ff\u5927\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4e00\u90e8\u5206\uff0c\u5df2\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u548c\u60a3\u8005\u4e2d\u8fdb\u884c\u4e86\u6d4b\u8bd5\u3002 \u8fd9\u6b3e\u836f\u7269\u4ee5\u7b80\u5355\u7684\u9f3b\u8154\u55b7\u5242\u5f62\u5f0f\u63d0\u4f9b\uff0c\u65e8\u5728\u6740\u6b7b\u4e0a\u547c\u5438\u9053\u75c5\u6bd2\uff0c\u9632\u6b62\u5176\u6ecb\u751f\u5e76\u4f20\u64ad\u5230\u80ba\u90e8\u3002\u5b83\u662f\u4e00\u79cd\u5929\u7136\u7eb3\u7c73\u5206\u5b50\u4e00\u6c27\u5316\u6c2e\uff08NO\uff09\uff0c\u5df2\u88ab\u8bc1\u660e\u5177\u6709\u6297\u83cc\u6027\u80fd\uff0c\u5bf9\u5bfc\u81f4\u65b0\u51a0\u80ba\u708e\u7684SARS-CoV-2\u75c5\u6bd2\u6709\u76f4\u63a5\u4f5c\u7528\u3002 2021\u5e747\u6708\u521d\uff0cGlenmark\u5411\u5370\u5ea6\u4e2d\u592e\u836f\u54c1\u6807\u51c6\u7ba1\u5236\u7ec4\u7ec7\uff08CDSCO\uff09\u4e3b\u9898\u4e13\u5bb6\u59d4\u5458\u4f1a\u63d0\u4ea4\u4e86\u4e00\u4efd\u63d0\u6848\uff0c\u8981\u6c42\u7d27\u6025\u6279\u51c6NONS\u7684\u8fdb\u53e3\u548c\u9500\u552e\u3002\u59d4\u5458\u4f1a\u5efa\u8bae\u5728\u5370\u5ea6\u60a3\u8005\u4e2d\u8fdb\u884cIII\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002NONS\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u9884\u8ba1\u5c06\u4e8e2021\u5e74\u5386\u5e74\u7b2c\u56db\u5b63\u5ea6\u5b8c\u6210\uff0c\u968f\u540e\u5c06\u4ee5FabiSpray&reg;\u54c1\u724c\u540d\u79f0\u5728\u5370\u5ea6\u5546\u4e1a\u53d1\u552e\u3002 \u201c\u81ea\u65b0\u51a0\u80ba\u708e\u7206\u53d1\u4ee5\u6765\uff0c\u6211\u4eec\u4e00\u76f4\u52aa\u529b\u4e3a\u60a3\u8005\u63d0\u4f9b\u5b89\u5168\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6848\u6765\u5bf9\u6297\u8fd9\u4e00\u75be\u75c5\u3002\u4e0eSaNOtize\u7684\u5408\u4f5c\u7d27\u5bc6\u8d34\u5408Glenmark\u9488\u5bf9\u65b0\u51a0\u80ba\u708e\u7684\u4e3b\u8981\u65b9\u6cd5\uff0c\u5e76\u5c06\u6709\u52a9\u4e8e\u51cf\u8f7b\u8be5\u5730\u533a\u75ab\u60c5\u7684\u8d1f\u62c5\uff0c\u201dGlenmark Pharmaceuticals Ltd\u8463\u4e8b\u957f\u517c\u603b\u7ecf\u7406Glenn Saldanha\u8868\u793a\u3002\u4ed6\u8fdb\u4e00\u6b65\u8865\u5145\u8bf4\uff1a\u201c\u8fd9\u4e5f\u6807\u5fd7\u7740\u6211\u4eec\u5728\u5173\u952e\u7684\u547c\u5438\u836f\u54c1\u6cbb\u7597\u9886\u57df\u7684\u53e6\u4e00\u5b9d\u8d35\u7684\u5f15\u5165\u8bb8\u53ef\u673a\u4f1a\uff0c\u4ee5\u53ca\u5728\u5168\u7403\u8303\u56f4\u5185\u5411SaNOtize\u53ca\u5176\u5408\u4f5c\u4f19\u4f34\u4f9b\u5e94\u8be5\u4ea7\u54c1\u7684\u53ef\u80fd\u6027\u3002Glenmark\u5c06\u786e\u4fdd\u53ca\u65f6\u548c\u5e7f\u6cdb\u83b7\u5f97\u8fd9\u79cd\u6709\u6548\u7684\u9f3b\u8154\u55b7\u96fe\uff0c\u6211\u4eec\u5e0c\u671b\u8fd9\u5c06\u4e3a\u8be5\u5730\u533a\u53ca\u5168\u4e16\u754c\u7684\u60a3\u8005\u5e26\u6765\u6025\u9700\u7684\u7f13\u89e3\u3002\u201d&nbsp; \u201c\u4e8b\u5b9e\u8bc1\u660e\uff0c\u5c3d\u7ba1\u75ab\u82d7\u5f00\u53d1\u8fc5\u901f\u5e76\u4e14\u5173\u952e\uff0c\u4f46\u65b0\u51a0\u75c5\u6bd2\u53ca\u5176\u5404\u79cd\u53d8\u79cd\u4ecd\u662f\u9700\u8981\u904f\u5236\u7684\u6311\u6218\uff0c\u201d SaNOtize\u9996\u5e2d\u6267\u884c\u5b98\u53ca\u8054\u5408\u521b\u59cb\u4ebaGilly Regev\u8868\u793a\u3002\u201cSaNOtize\u5f88\u9ad8\u5174\u80fd\u4e0eGlenmark\u5408\u4f5c\uff0c\u4f7f\u5176\u6cbb\u7597\u836f\u7269\u66f4\u7b80\u5355\u5730\u8ba9\u66f4\u591a\u7684\u4eba\u7528\u5f97\u5230\u3001\u7528\u5f97\u8d77\u3002&nbsp;\u5728\u4e0eGlenmark\u643a\u624b\u5408\u4f5c\u7684\u8fc7\u7a0b\u4e2d\uff0cSaNOtize\u53ef\u4ee5\u52a0\u5feb\u52aa\u529b\u901f\u5ea6\uff0c\u4f7f\u5176\u6297\u75c5\u6bd2\u9f3b\u8154\u55b7\u5242\u5728\u5f53\u524d\u75ab\u60c5\u671f\u95f4\u4f5c\u4e3a\u81ea\u5df1\u7ed9\u836f\u5bf9\u6297\u65b0\u51a0\u80ba\u708e\u7684\u7b2c\u4e00\u9053\u9632\u7ebf\uff0c\u5e76\u5e2e\u52a9\u9632\u6b62\u672a\u6765\u75ab\u60c5\u7206\u53d1\u3002\u201d&nbsp; NONS\u662f\u6602\u8d35\u7684\u5355\u514b\u9686\u6297\u4f53\u4ee5\u5916\u4e3a\u6570\u4e0d\u591a\u7684\u51e0\u79cd\u65b0\u578b\u6cbb\u7597\u65b9\u6cd5\u4e4b\u4e00\uff0c\u5df2\u88ab\u8bc1\u660e\u53ef\u4ee5\u51cf\u5c11\u4eba\u4f53\u4e2d\u65b0\u51a0\u75c5\u6bd2\u8f7d\u91cf\u3002[2]NONS\u5df2\u5728\u6b27\u6d32\u83b7\u5f97CE\u6807\u5fd7\uff0c\u8fd9\u76f8\u5f53\u4e8e\u533b\u7597\u5668\u68b0\u7684\u4e0a\u5e02\u8bb8\u53ef\uff08CE\u6807\u5fd7\u786e\u8ba4\u533b\u7597\u5668\u68b0\u7b26\u5408\u6b27\u6d32\u901a\u7528\u533b\u7597\u5668\u68b0\u6307\u4ee4\u7684\u67d0\u4e9b\u201c\u57fa\u672c\u8981\u6c42\u201d\uff0c\u5e76\u4e14\u5bf9\u9884\u671f\u7528\u9014\u662f\u5b89\u5168\u7684\uff09\u3002\u51ed\u501fCE\u6807\u5fd7\uff0cSaNOtize\u5df2\u83b7\u5f97\u5728\u6b27\u6d32\u53d1\u5e03NONS\u7684\u8bb8\u53ef\u3002NONS\u4e5f\u83b7\u5f97\u4e86\u5728\u4ee5\u8272\u5217\u548c\u5df4\u6797\u4ee5\u540d\u79f0enovid&#x2122;\u8fdb\u884c\u9500\u552e\u7684\u8bb8\u53ef\u3002 SaNOtize\u57282017\u5e74\u5f00\u53d1\u4e86\u7528\u4e8e\u6cbb\u7597\u548c\u9884\u9632\u5fae\u751f\u7269\u611f\u67d3\u7684\u4e00\u6c27\u5316\u6c2e\u91ca\u653e\u6eb6\u6db2\u5e73\u53f0\u6280\u672f\uff08NORS&#x2122;\uff09\u5e76\u83b7\u5f97\u4e86\u4e13\u5229\u3002Glenmark\u4e0eSaNOtize\u7684\u5408\u4f5c\u5c06\u4e3a\u5370\u5ea6\u548c\u4e9a\u6d32\u7684\u60a3\u8005\u5e26\u6765\u6025\u9700\u7684\u6cbb\u7597\u7f13\u89e3\u3002 [1]SaNOtize\u7684\u201c\u9769\u547d\u6027\u201d\u65b0\u51a0\u75c5\u6bd2\u9f3b\u55b7\u96fe\u83b7\u5f97II\u671f\u4e34\u5e8a\u6570\u636e\u652f\u6301\u3002\u8be6\u60c5\u8bf7\u8bbf\u95eehttps:\/\/www.clinicaltrialsarena.com\/news\/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail\/ [2]SaNOtize\u7684\u201c\u9769\u547d\u6027\u201d\u65b0\u51a0\u75c5\u6bd2\u9f3b\u55b7\u96fe\u83b7\u5f97II\u671f\u4e34\u5e8a\u6570\u636e\u652f\u6301\u3002\u8be6\u60c5\u8bf7\u8bbf\u95eehttps:\/\/www.clinicaltrialsarena.com\/news\/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail\/ &nbsp;&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2021080315240039893\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":39896,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-39893","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/39893","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=39893"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/39893\/revisions"}],"predecessor-version":[{"id":39895,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/39893\/revisions\/39895"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/39896"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=39893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=39893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=39893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}